As with all transcutaneous procedures, injection of these products carries a risk of infection. Injection in the jawline may temporarily alter jaw function.
Introduction of product into the vasculature may lead to embolization, occlusion of the vessels, ischemia, or infarction. Take Em excesso care when injecting soft tissue fillers, for example inject the product slowly and apply the least amount of pressure necessary. Rare but serious adverse events associated with the intravascular injection of soft tissue fillers in the face have been reported and include temporary or permanent vision impairment, blindness, cerebral ischemia or cerebral hemorrhage, leading to stroke, skin necrosis, and damage to underlying facial structures.
RADIESSE® and RADIESSE® (+) are dermal fillers that are used for smoothing moderate to severe facial wrinkles and folds, such as nasolabial folds (the creases that extend from the corner of your nose to the corner of your mouth).
Use of these products in any person with active skin inflammation or infection in or near the treatment should be deferred until the inflammatory or infectious process is controlled.
Patients should minimize strenuous activity and exposure of the treated area to extensive sun or heat exposure for approximately 24 hours after treatment or until any initial swelling and redness has resolved.
Interactions between RADIESSE® or RADIESSE® (+) and drugs or other substances or implants Use during pregnancy, or in breastfeeding women
The safety and effectiveness of RADIESSE® or RADIESSE® (+) in the following situations has not been established:
Healthcare practitioners should fully familiarize themselves with the product, the product educational materials and the entire package insert.
You should minimize strenuous activity and avoid extensive sun or heat exposure for about 24 hours after treatment and until any swelling or redness has resolved.
Delayed-onset inflammation near the site of injection is one of the known adverse events associated with dermal fillers. Cases of delayed-onset inflammation have been reported to occur at the treatment site following viral or bacterial illnesses or infections, vaccinations, or dental procedures. Typically, the reported inflammation was responsive to treatment or resolved on its own.
Cases of delayed-onset inflammation have been reported to occur at the dermal filler treatment site following viral or bacterial illnesses or infections, vaccinations, or dental procedures. Typically, the reported inflammation was responsive to treatment or resolved on its own.
Quem acompanha em algum momento minhas postagens sabe que eu faço esse Espécie procedimento uma vez ao ano – e vou alternando marcas multiplos de modo a conhecer e poder explicar melhor de modo a vocês. Bora?
Este LIFTERA está pronto para ser O MAIS PROVEITOSO parceiro dos dermatologistas oferecendo expertise e tecnologias por ponta, para além de novas possibilidades de procedimento e melhores fins, usando demasiado mais segurança e conforto de modo a especialistas e pacientes.
Liftera possui dois tipos do aplicadores: a exclusiva e inovadora Caneta Liftera e este aplicador botox em linha.